Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Warpaint beats expectations after strong fourth quarter

(Sharecast News) - Colour cosmetics specialist Warpaint London issued a positive trading update for the financial year just ended on Friday. The AIM-traded firm, in its previous update on 10 November, had anticipated sales for the year ended 31 December to be a minimum of £85m, surpassing the 2022 figure of £64.1m.

However, following a strong performance in the fourth quarter, Warpaint said its full-year sales for 2023 had exceeded that, reaching £89.5m.

The group said it maintained a robust gross product margin, surpassing the levels achieved in 2022.

As a result, it expected to report a profit before tax of at least £18m for the year - a significant increase compared to the prior year's £7.7m.

The performance exceeded both market expectations and the board's prior guidance of profit before tax in excess of £16m, as announced on 10 November.

Warpaint London said it maintained a strong financial position, with cash balances at the end of December totalling £9m - an increase from £5.9m year-on-year.

The company also had no outstanding debt.

Warpaint said it would release its full-year results for the year ended 31 December in April.

At 0856 GMT, shares in Warpaint London were up 2.02% at 389.7p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

AstraZeneca makes progress with two breast cancer treatments
(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.
Insurer Beazley keeps guidance after solid Q1 premiums growth
(Sharecast News) - Insurance group Beazley said that first-quarter results were in line with guidance with insurance written premiums (IWP) growing at high single digits.
Blackstone ups bid for Hipgnosis with $1.57bn offer
(Sharecast News) - Music rights owner Hipgnosis said it it agreed terms on a £1.2bn takeover by private equity investor Blackstone, in the latest tit-for-tat battle with rival Concord.
Aukett Swanke flags delays to some contracts
(Sharecast News) - Smart buildings, architectural and design services specialist Aukett Swanke said in an update on Friday that, as outlined in its recent financial statements, it maintained a robust pipeline of interest, although a number of projects had been pushed back.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.